Stockscreener 앱 받기
73.07
1.22%
-0.90
시간 외 거래:
73.39
0.32
+0.44%
전일 마감가:
$73.97
열려 있는:
$75
하루 거래량:
21,736
Relative Volume:
1.75
시가총액:
$232.66M
수익:
$37.53M
순이익/손실:
$10.85M
주가수익비율:
21.62
EPS:
3.3794
순현금흐름:
$14.32M
1주 성능:
+10.48%
1개월 성능:
+9.96%
6개월 성능:
+27.86%
1년 성능:
+26.42%
1일 변동 폭
$73.07
$75.00
1주일 범위
$64.81
$75.75
52주 변동 폭
$53.66
$75.75
Utah Medical Products Inc Stock (UTMD) Company Profile
명칭
Utah Medical Products Inc
전화
(801) 521-5301
주소
7043 S 300 WEST, MIDVALE, UT
Compare UTMD vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTMD
Utah Medical Products Inc
|
73.07 | 235.52M | 37.53M | 10.85M | 14.32M | 3.3794 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Utah Medical Products Inc 주식(UTMD)의 최신 뉴스
Utah Medical's Q1 earnings fall y/y due to elevated litigation costs - MSN
Responsive Playbooks and the UTMD Inflection - Stock Traders Daily
World Postpartum Hemorrhage Treatment DeviceMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Utah Medical Products Inc (UTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Monopolar Grounding Pad Electrodes Market Growth Outlook to 2035: Surgical Demand and Product Innovation AccelerateNews and Statistics - IndexBox
World Peripheral Arterial Line TransducersMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
World Cautery Pencils and HandlesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Utah Medical Products Inc (UTMD) Institutional Confidence - TradingKey
Utah Medical Products Inc (UTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Utah Medical Products Inc (UTMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Utah Medical Products Inc (UTMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Utah Medical Products StockThursday chart snapshot and volatility check - Ad-hoc-news.de
Utah Medical Products Inc (UTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Utah Medical Products Inc (UTMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Utah Medical Products Inc (UTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Utah Medical Products Inc (UTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Utah Medical Products, Inc.: - marketscreener.com
UTMD Q1 2024 Earnings: EPS of $1.09 Drives Positive Stock Reaction Amid Limited Financial Disclosure - newsline.com
UTMD Q1 2024 Earnings: EPS of $1.09 Highlights Stability Amid Stock PullbackEarnings Growth Analysis - newsline.com
UTMD Q1 2024 Earnings: EPS of $1.09 as Stock Declines 2.3% Amid Quiet ReleaseLow Estimate Range - newsline.com
US Infant Incubator Market Size to Hit USD 442.25 Million by 2035 - Precedence Research
UTMD Q1 2024 Earnings: EPS of $1.09 Drives Positive Stock ReactionEBITDA Estimate Trend - newsline.com
Paytm to Hire 4,000 in AI Push While Cutting 400 Jobs Amid Regulatory RevampProfit Inflection Point - newsline.com
The Technical Signals Behind (UTMD) That Institutions Follow - Stock Traders Daily
World Surgical Drainage DevicesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah - Yahoo Finance
Top analyst reports for Berkshire Hathaway, Eli Lilly & Walmart - MSN
Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart - Yahoo Finance
Miniature High-Frequency Needle Electrode Research: a CAGR of 6.18% during the forecast period - openPR.com
Utah’s Medical Cannabis Program sees growth, but high cost remains a barrier, new survey shows - ABC4 Utah
Utah Medical gains 32% in a year: Should you buy the stock? - MSN
UTAH MEDICAL (UTMD) finance chief reports 50-share stock gift - Stock Titan
UTMD Q1 2024 Earnings: EPS of $1.09 Drives Positive Stock MovementEarnings Season Outlook - The Legal Advocate
UTMD Q1 2024 Earnings: EPS of $1.09 Highlights Strong Profitability Amid Steady OperationsEarnings Trend Analysis - The Legal Advocate
UTMD Q1 2024 Earnings: EPS of $1.09 Highlights Operational Stability Amid Quiet QuarterEarnings Whisper Number - The Legal Advocate
Precision Trading with Utah Medical Products Inc. (UTMD) Risk Zones - Stock Traders Daily
Utah Medical Products Inc. (UTMD) Q1 2024 Earnings: EPS of $1.09 Reported, Stock Gains ModestlyMargin Compression Risk - The Legal Advocate
The Bull Case For Merit Medical Systems (MMSI) Could Change Following Governance Bylaw Overhaul And New Director Appointment - simplywall.st
Utah Medical Products Edges Lower as Stock Holds Between Key Support and Resistance LevelsEntry Point Alerts - The Legal Advocate
World Fetal Labor and Delivery and Neonatal EquipmentMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Thoracic Drainage Devices Market Size, Share, Growth, Analysis, 2034 - Straits Research
UTMD Q1 2024 Earnings: Solid EPS Performance Amidst Cautious Market ReactionRevenue Per Share - The Legal Advocate
Filshie Clip Malfunction Lawsuit Claims Defective Birth Control Implants Caused Severe Pain - AboutLawsuits.com
ICU Medical Reports Q1 2026 Results: Revenue and EPS Top Wall Street ConsensusNews and Statistics - IndexBox
Technical Reactions to UTMD Trends in Macro Strategies - Stock Traders Daily
Utah (UTMD) Slips -0.72%, Testing $60.08 Support 2026-05-15Price Surge - newser.com
Brandes Investment Partners holds 14.12% of Utah Medical Products (NASDAQ: UTMD) - Stock Titan
Utah Medical Products: I Can't Upgrade Shares Until Sales Stabilize (UTMD) - Seeking Alpha
World Electrocautery Enhanced Delivery SystemMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Utah Medical Products (NASDAQ: UTMD) Q1 2026 sales and profit decline - Stock Titan
Utah Medical Products Inc (UTMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):